{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:07:53Z","timestamp":1757311673105},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00347-019-00955-z","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T07:02:46Z","timestamp":1568790166000},"page":"982-988","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pulslichttherapie (\u201eintense pulsed light\u201c) als Therapieoption bei der Behandlung der Meibom-Dr\u00fcsen-Dysfunktion"],"prefix":"10.1007","volume":"116","author":[{"given":"A.","family":"Schuh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. M.","family":"Messmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"issue":"5","key":"955_CR1","first-page":"71","volume":"112","author":"EM Messmer","year":"2015","unstructured":"Messmer\u00a0EM (2015) The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int 112(5):71\u201381 (quiz 82)","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"955_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1442-9071.2003.00634.x","volume":"31","author":"EM Chia","year":"2003","unstructured":"Chia\u00a0EM et\u00a0al (2003) Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol 31(3):229\u2013232","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"955_CR3","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","volume":"52","author":"JD Nelson","year":"2011","unstructured":"Nelson\u00a0JD et\u00a0al (2011) The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci 52(4):1930\u20131937","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"955_CR4","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1167\/iovs.11-9228","volume":"53","author":"E Viso","year":"2012","unstructured":"Viso\u00a0E et\u00a0al (2012) Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci 53(6):2601\u20132606","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2 Suppl","key":"955_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","volume":"12","author":"AJ Bron","year":"2014","unstructured":"Bron\u00a0AJ et\u00a0al (2014) Rethinking dry eye disease: a\u00a0perspective on clinical implications. Ocul Surf 12(2 Suppl):S1\u2013S31","journal-title":"Ocul Surf"},{"issue":"1","key":"955_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/01.ICL.0000095229.01957.89","volume":"30","author":"JM Romero","year":"2004","unstructured":"Romero\u00a0JM et\u00a0al (2004) Conservative treatment of meibomian gland dysfunction. Eye Contact Lens 30(1):14\u201319","journal-title":"Eye Contact Lens"},{"issue":"6","key":"955_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/0275-5408(95)00071-K","volume":"15","author":"JP Craig","year":"1995","unstructured":"Craig\u00a0JP, Blades\u00a0K, Patel\u00a0S (1995) Tear lipid layer structure and stability following expression of the meibomian glands. Ophthalmic Physiol Opt 15(6):569\u2013574","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"955_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/OPX.0000000000000134","volume":"91","author":"PS Bilkhu","year":"2014","unstructured":"Bilkhu\u00a0PS, Naroo\u00a0SA, Wolffsohn\u00a0JS (2014) Effect of a\u00a0commercially available warm compress on eyelid temperature and tear film in healthy eyes. Optom Vis Sci 91(2):163\u2013170","journal-title":"Optom Vis Sci"},{"issue":"3","key":"955_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/ICO.0000000000000051","volume":"33","author":"B Sobolewska","year":"2014","unstructured":"Sobolewska\u00a0B et al (2014) Treatment of ocular rosacea with once-daily low-dose doxycycline. Cornea 33(3):257\u2013260","journal-title":"Cornea"},{"issue":"4","key":"955_CR10","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","volume":"52","author":"G Geerling","year":"2011","unstructured":"Geerling\u00a0G et\u00a0al (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 52(4):2050\u20132064","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"955_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","volume":"30","author":"J Yu","year":"2011","unstructured":"Yu\u00a0J, Asche\u00a0CV, Fairchild\u00a0CJ (2011) The economic burden of dry eye disease in the United States: a\u00a0decision tree analysis. Cornea 30(4):379\u2013387","journal-title":"Cornea"},{"issue":"3","key":"955_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/j.1365-2133.2008.08702.x","volume":"159","author":"P Papageorgiou","year":"2008","unstructured":"Papageorgiou\u00a0P et al (2008) Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results. Br J Dermatol 159(3):628\u2013632","journal-title":"Br J Dermatol"},{"issue":"2","key":"955_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/lsm.10145","volume":"32","author":"C Raulin","year":"2003","unstructured":"Raulin\u00a0C, Greve\u00a0B, Grema\u00a0H (2003) IPL technology: a\u00a0review. Lasers Surg Med 32(2):78\u201387","journal-title":"Lasers Surg Med"},{"issue":"3","key":"955_CR14","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1167\/iovs.14-15764","volume":"56","author":"JP Craig","year":"2015","unstructured":"Craig\u00a0JP, Chen\u00a0YH, Turnbull\u00a0PR (2015) Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 56(3):1965\u20131970","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"955_CR15","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2147\/OPTH.S130706","volume":"11","author":"SJ Dell","year":"2017","unstructured":"Dell\u00a0SJ et\u00a0al (2017) Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol 11:817\u2013827","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"955_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/pho.2014.3819","volume":"33","author":"R Toyos","year":"2015","unstructured":"Toyos\u00a0R, McGill\u00a0W, Briscoe\u00a0D (2015) Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a\u00a03-year retrospective study. Photomed Laser Surg 33(1):41\u201346","journal-title":"Photomed Laser Surg"},{"issue":"4","key":"955_CR17","first-page":"746","volume":"17","author":"JP Kalangara","year":"2016","unstructured":"Kalangara\u00a0JP et\u00a0al (2016) Burning eye syndrome: Do neuropathic pain mechanisms underlie chronic dry eye? Pain Med 17(4):746\u2013755","journal-title":"Pain Med"},{"issue":"2","key":"955_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/mus.20095","volume":"30","author":"J Irvine","year":"2004","unstructured":"Irvine\u00a0J et al (2004) Double-blind randomized controlled trial of low-level laser therapy in carpal tunnel syndrome. Muscle Nerve 30(2):182\u2013187","journal-title":"Muscle Nerve"},{"key":"955_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1745-6215-14-229","volume":"14","author":"CH de Godoy","year":"2013","unstructured":"de Godoy\u00a0CH et al (2013) Evaluation of effect of low-level laser therapy on adolescents with temporomandibular disorder: study protocol for a\u00a0randomized controlled trial. Trials 14:229","journal-title":"Trials"},{"issue":"9","key":"955_CR20","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/(SICI)1097-4598(199809)21:9<1232::AID-MUS23>3.0.CO;2-S","volume":"21","author":"L Padua","year":"1998","unstructured":"Padua\u00a0L et\u00a0al (1998) Noninvasive laser neurolysis in carpal tunnel syndrome. Muscle Nerve 21(9):1232\u20131233","journal-title":"Muscle Nerve"},{"issue":"12","key":"955_CR21","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.1167\/iovs.11-8113","volume":"52","author":"WR Kam","year":"2011","unstructured":"Kam\u00a0WR, Sullivan\u00a0DA (2011) Neurotransmitter influence on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci 52(12):8543\u20138548","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"955_CR22","first-page":"238","volume":"37","author":"CW Chung","year":"1996","unstructured":"Chung\u00a0CW, Tigges\u00a0M, Stone\u00a0RA (1996) Peptidergic innervation of the primate meibomian gland. Invest Ophthalmol Vis Sci 37(1):238\u2013245","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"955_CR23","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2014.11132","volume":"312","author":"MR DeLong","year":"2014","unstructured":"DeLong\u00a0MR, Benabid\u00a0AL (2014) Discovery of high-frequency deep brain stimulation for treatment of Parkinson disease: 2014 Lasker Award. JAMA 312(11):1093\u20131094","journal-title":"JAMA"},{"issue":"5","key":"955_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.biotechadv.2012.08.003","volume":"31","author":"A Gupta","year":"2013","unstructured":"Gupta\u00a0A et\u00a0al (2013) Shining light on nanotechnology to help repair and regeneration. Biotechnol Adv 31(5):607\u2013631","journal-title":"Biotechnol Adv"},{"key":"955_CR25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jphotobiol.2014.07.021","volume":"140","author":"S Passarella","year":"2014","unstructured":"Passarella\u00a0S, Karu\u00a0T (2014) Absorption of monochromatic and narrow band radiation in the visible and near IR by both mitochondrial and non-mitochondrial photoacceptors results in photobiomodulation. J\u00a0Photochem Photobiol\u00a0B 140:344\u2013358","journal-title":"J Photochem Photobiol B"},{"issue":"1","key":"955_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/phpp.12282","volume":"33","author":"A Yadav","year":"2017","unstructured":"Yadav\u00a0A, Gupta\u00a0A (2017) Noninvasive red and near-infrared wavelength-induced photobiomodulation: promoting impaired cutaneous wound healing. Photodermatol Photoimmunol Photomed 33(1):4\u201313","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"4","key":"955_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/01.ASW.0000553600.97572.d2","volume":"32","author":"RC Mosca","year":"2019","unstructured":"Mosca\u00a0RC et\u00a0al (2019) Photobiomodulation therapy for wound care: a potent, noninvasive, photoceutical approach. Adv Skin Wound Care 32(4):157\u2013167","journal-title":"Adv. Skin. Wound Care."},{"issue":"4","key":"955_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.det.2009.08.006","volume":"27","author":"WE Roberts","year":"2009","unstructured":"Roberts\u00a0WE (2009) Skin type classification systems old and new. Dermatol Clin 27(4):529\u2013533, viii","journal-title":"Dermatol Clin"},{"issue":"4","key":"955_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jcjo.2016.01.005","volume":"51","author":"PK Gupta","year":"2016","unstructured":"Gupta\u00a0PK et\u00a0al (2016) Outcomes of intense pulsed light therapy for treatment of evaporative dry eye disease. Can J Ophthalmol 51(4):249\u2013253","journal-title":"Can J Ophthalmol"},{"key":"955_CR30","first-page":"1910694","volume":"2016","author":"X Jiang","year":"2016","unstructured":"Jiang\u00a0X et\u00a0al (2016) Evaluation of the safety and effectiveness of intense pulsed light in the treatment of meibomian gland dysfunction. J\u00a0Ophthalmol 2016:1910694","journal-title":"J Ophthalmol"},{"issue":"4","key":"955_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/IOP.0b013e31820c6e23","volume":"27","author":"WW Lee","year":"2011","unstructured":"Lee\u00a0WW et\u00a0al (2011) Ocular damage secondary to intense pulse light therapy to the face. Ophthalmic Plast Reconstr Surg 27(4):263\u2013265","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"issue":"4","key":"955_CR32","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jcjo.2012.01.019","volume":"47","author":"H Jewsbury","year":"2012","unstructured":"Jewsbury\u00a0H, Morgan\u00a0F (2012) Uveitis and iris photoablation secondary to intense pulsed light therapy. Can J Ophthalmol 47(4):e13\u20134","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"955_CR33","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig\u00a0JP et\u00a0al (2017) TFOS DEWS II report executive summary. Ocul Surf 15(4):802\u2013812","journal-title":"Ocul Surf"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-00955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-019-00955-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-00955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T23:22:15Z","timestamp":1664407335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-019-00955-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1007\/s00347-019-00955-z","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"18 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Schuh, S.\u00a0Priglinger und E.M.\u00a0Messmer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}